Lyndra
is a Massachusetts-based biopharmaceutical company that researches and develops oral therapies for the treatment of schizophrenia and central nervous system disorders... Read moreLyndra
is a Massachusetts-based biopharmaceutical company that researches and develops oral therapies for the treatment of schizophrenia and central nervous system disorders... Read more
News
Mar 27, 2025
The Hindu Business Line
Lyndra: US-based Lyndra Therapeutics ceases operations due to "insufficient funding", says Sun Pharma
Mar 25, 2025
The Business Journals: Boston
Lyndra: Biotech spinout from MIT's Langer Lab winds down operations
Jan 16, 2025
Biospectrum Asia
Lyndra: Lyndra Therapeutics inks manufacturing services collaboration with Thermo Fisher for long-acting oral therapies
Jan 04, 2024
Business Wire
Press Release: Lyndra : Lyndra Therapeutics Announces Positive Data from Pivotal Phase 3 Study with Oral Weekly Risperidone (LYN-005) for Schizophrenia
Jan 04, 2024
Endpoints News
Lyndra: Lyndra's long-acting risperidone formulation hits PhIII schizophrenia trial endpoints
Jan 02, 2024
Indian Pharma Post
Lyndra: Sun Pharma to acquire 16.7% stake in Lyndra Therapeutics for $30 mn
Dec 19, 2023
Powder and Bulk Solids
Lyndra: Sun Pharma to Acquire 16.7% Stake in Lyndra Therapeutics for $30M
Sep 15, 2023
Endpoints News
Lyndra: Lyndra lays off 23% of workers, to outsource manufacturing as it approaches pivotal readout next month
Aug 01, 2023
DERGEL Media
Lyndra: Lyndra Therapeutics [WATERTOWN, MA] announced long-time Lyndra executive President and Chief Operations Officer Jessica Ballinger has been appointed President and CEO. Current Senior Vice President of People and Operations Lindsay Beaupre has been appointed to Chief People and Workplace Operations Officer
Jul 18, 2023
BioCentury
Lyndra: Ballinger at the helm at Lyndra
Lyndra Competitors
1
2
3
4
5
6
7
8
9
10